We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA OKs Medtronic's New Glucose Monitor

Law360 (July 18, 2006, 12:00 AM EDT) -- Medical device maker Medtronic Inc. said Monday it has received U.S. Food and Drug Administration (FDA) approval for a doctor-prescribed continuous glucose monitoring system designed to improve diabetes management.

The Guardian Real-Time System, intended for people who frequently monitor their glucose levels, alerts users to high and low glucose levels. A tiny electrode inserted under the skin, the device allows patients to use real-time data and trend analysis to help control glucose levels, Medtronic said.

“The Guardian Real-Time System is the culmination of more than seven...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.